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Abstract
Shiga toxin-producing Escherichia coli (STEC) cause infections in humans ranging from asymptomatic carriage to bloody
diarrhoea and haemolytic uremic syndrome (HUS). Here we present whole genome comparison of Norwegian non-O157
STEC strains with the aim to distinguish between strains with the potential to cause HUS and less virulent strains. Whole
genome sequencing and comparisons were performed across 95 non-O157 STEC strains. Twenty-three of these were
classified as HUS-associated, including strains from patients with HUS (n = 19) and persons with an epidemiological link to a
HUS-case (n = 4). Genomic comparison revealed considerable heterogeneity in gene content across the 95 STEC strains. A
clear difference in gene profile was observed between strains with and without the Locus of Enterocyte Effacement (LEE)
pathogenicity island. Phylogenetic analysis of the core genome showed high degree of diversity among the STEC strains,
but all HUS-associated STEC strains were distributed in two distinct clusters within phylogroup B1. However, non-HUS
strains were also found in these clusters. A number of accessory genes were found to be significantly overrepresented
among HUS-associated STEC, but none of them were unique to this group of strains, suggesting that different sets of genes
may contribute to the pathogenic potential in different phylogenetic STEC lineages. In this study we were not able to clearly
distinguish between HUS-associated and non-HUS non-O157 STEC by extensive genome comparisons. Our results indicate
that STECs from different phylogenetic backgrounds have independently acquired virulence genes that determine
pathogenic potential, and that the content of such genes is overlapping between HUS-associated and non-HUS strains.
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Introduction
Shiga toxin producing E. coli (STEC) are important human
pathogens known to cause infections ranging from diarrhoea and
haemorrhagic colitis to haemorrhagic uremic syndrome (HUS)
[1]. Since the first reports of disease caused by O157:H7 in 1982
[2,3], this serotype has been the most frequently reported cause of
severe STEC disease and outbreaks worldwide [1]. However,
several non-O157 STEC serogroups (e.g. O26, O45, O103,
O111, O121 and O145) have also been recognized to be
responsible for severe disease and outbreaks [4,5].
The STEC pathotype is defined by the presence of Shiga toxins
Stx1 and Stx2 encoded by the stx1 and stx2 genes, which are
acquired through horizontal gene transfer of a heterogeneous
group of lambdoid bacteriophages [6–9]. There are several
subtypes of Shiga toxins, of which the Stx2 subtypes Stx2a, Stx2c
and Stx2d are more often associated with HUS than other Stx
subtypes [10–13]. In addition, the adherence factor intimin,
encoded by the eae gene located in the Locus of Enterocyte
Effacement (LEE) pathogenicity island, is important for STEC
pathogenicity. STEC causing severe disease and outbreaks do
usually harbour LEE [1,14,15], although also LEE negative STEC
are sometimes found in patients with severe disease [15–21]. LEE
encodes several genes responsible for the attaching and effacing
nature of STEC, a feature that these bacteria share with the closely
related enteropathogenic E. coli (EPEC). In addition, the LEE
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from the EMBL-EBI (ENA) database - http://www.ebi.ac.uk/ena/ (accession number(s) ERS480133–ERS480228). Study accession: http://www.ebi.ac.uk/ena/data/
encodes additional associated regulators, translocators, effector
proteins and chaperones [22,23].
Whole genome sequencing of bacterial genomes has become an
accessible and affordable analysis. Comparison of whole genome
sequences provides information on gene content and organization,
and gives an overview of how organisms are related. Whole
genome sequences available of STEC and other E. coli have
demonstrated high diversity among different E. coli genomes, due
to horizontal gene transfer, gene loss and other genomic
alterations [20,24–34]. Genomic comparisons of O157 and non-
O157 LEE positive STEC genomes with other E. coli and Shigella
have also revealed that LEE positive STEC in general have larger
genomes, mostly due to horizontally transferred DNA such as
prophage DNA, plasmids and integrative elements encoding
potential virulence factors [24–26].
In Norway non-O157 STEC are more frequently isolated from
patients with STEC disease than O157, and are also more
common than O157 STEC in patients suffering from HUS [35].
Although whole genome sequence comparisons of O157 and non-
O157 STEC are available [20,25,28], it is still unclear whether it is
possible to differentiate between STEC strains based on their
potential to cause HUS. In this study our main aim was to
compare whole genome sequences from 95 non-O157 human
STEC strains to investigate potential genetic differences suitable
for distinguishing between highly pathogenic STEC having caused
HUS and low-virulent STEC having caused only mild disease or
asymptomatic carriage. We were not able to clearly distinguish
between HUS-associated and non-HUS non-O157 STEC by
extensive genome comparisons in this study. Our results indicate
that STEC from different phylogenetic backgrounds have
independently acquired virulence genes that determine pathogenic
potential, and that the content of such genes is overlapping
between HUS-associated and non-HUS strains. To our knowledge
this is the largest collection of non-O157 STEC strains that has
been sequenced to date, thus providing valuable data on the less
characterized STEC serotypes.
Results
Sequencing and whole genome comparison of the 95 non-O157
STEC strains included in this study revealed high degree of
variation in gene content as well as diversity in whole genome
phylogeny. A total of 1,954 genes represented the core genome
among the 95 strains, while 26,073 genes represented the pan
genome. The LEE pathogenicity island was identified in 54 (57%)
of the genomes, whereas 41 (43%) of the sequenced STEC strains
were LEE negative (Table 1). Stx genes were detected in 84 (88%)
genomes; stx1 in 35 (37%), stx2 in 37 (39%) and a combination of
stx1 and stx2 in 12 (13%) of the genomes (Table 1). Eleven (12%)
of the sequenced genomes which did not harbour stx genes, were
classified as STEC-LST (Table 1). The stx2 subtypes were
differently distributed: stx2a was significantly more frequent
among LEE positive STEC, while stx2b was more frequent
among LEE negative strains (p,0.05 for both analyses) (Table 1).
Of the stx1 subtypes, stx1c was significantly associated with LEE
negative STEC.
In the present study, all 19 STEC strains from patients with
HUS were from children ,5 years old (Table S1 in File S1). An
additional four strains were epidemiologically linked to a HUS-
case, and consequently 23 strains were classified as HUS-
associated (Table S1 in File S1). All the HUS-associated STEC
strains harboured the LEE pathogenicity island, and except for six
STEC-LST of serotype O103:H25 from the same outbreak, all
contained the stx2a subtype. Only one STEC from a HUS patient
(FHI6) harboured stx1 (subtype stx1a), in addition to stx2a (Table
S1 in File S1).
Phylogenetic analysis of the core genome
A core gene tree was constructed from alignment of the 1,861
core genes present in all the 95 STEC and 14 E. coli reference
genomes representing the E. coli phylogroups (109 genomes in
total). In this phylogenetic tree, the 95 strains were distributed in
the E. coli phylogroups A, B1, B2, D and E (Figure 1). In general,
clusters of LEE negative STEC strains were distributed between
clusters of LEE positive strains. Most of the strains belonged to the
B1 phylogroup, and a majority of the LEE positive STEC strains
were also found within this group. All HUS-associated strains were
found in phylogroup B1, in two clusters which we designated
HUS-group 1 and 2 (Figure 1). The STEC strains in HUS-group
1 were distributed in three related clusters, consisting of mainly
HUS and HUS-associated strains of serotypes O103:H25,
O145:H[unknown], and O121:H- (n = 18) (Figure 1, Figure S1).
HUS-group 2 consisted of one distinct cluster of strains (n = 23), in
which all HUS and HUS-associated STEC strains of serogroups
O26, O86 and O111 were located. Sixteen of the strains in HUS-
group 2, of which 13 strains were of serogroup O26, were not
associated with HUS (Figure 1, Figure S1). This group therefore
appeared to be more heterogeneous than HUS-group 1 with
respect to pathogenicity.
Comparative analysis of the accessory genome
The accessory genome consisted of approximately 24,000 genes.
PCA of the accessory genome separated LEE positive (n = 54,
Table S1 in File S1) and LEE negative (n = 41) STEC strains in
two distinct groups (data not shown). PCA and PLS regression of
LEE positive strains (n = 54) as well as of LEE positive/stx2
positive strains (n = 33, Table S1 in File S1) could not further
separate the strains into subgroups. In a random forest analysis of
the accessory genome in the LEE positive strains (n = 54) 18 of the
23 HUS-associated strains were correctly classified as HUS-
strains, whereas 29 of the 31 non-HUS strains were correctly
classified (Table S2 in File S2, Figure S2). However, a perfect
separation of the two groups could not be achieved.
By comparison of all 54 LEE positive STEC strains, we
identified eleven genes which were more frequent in the HUS-
associated strains (n = 23) and four genes which were more
frequent in non-HUS STEC strains (n = 31) (p,0.01, FDR)
(Table 2, Table S3 in File S2). None of these genes were however
present exclusively in one of these two groups. Among the 33 LEE
positive STEC strains containing stx2 (Table S1 in File S1), we
identified 69 genes which were overrepresented in HUS-associated
strains (n = 23) and 44 genes which were more frequent in non-
HUS STEC strains (n = 10) (p,0.01, data uncorrected) (Table 2,
Table S4 in File S2).
When STEC strains in HUS-group 1 (n = 18, Figure 1) were
compared with all other LEE positive strains (n = 36), 357 genes
were more frequent in HUS-group 1 strains (p,0.01, FDR)
(Table 2, Table S5 in File S2). One gene encoding a hypothetical
protein (Table S5 in File S2) was present in all strains in HUS-
group 1 but absent in other LEE positive STEC. This gene was
however present in one LEE negative strain. When STEC strains
in HUS-group 2 (n= 23) were compared with all other LEE
positive STEC strains (n = 31), 576 genes were overrepresented in
the former group (p,0.01, FDR) (Table 2, Table S6 in File S2).
Four genes were present in all strains in HUS-group 2 while absent
in the other strains (Table 2, Table S6 in File S2). Seventeen genes
were overrepresented in HUS-associated serogroup O26 strains in
HUS-group 2 (n = 5), whereas 13 genes were more frequent in the
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non-HUS strains of the same serogroup (n= 13) (p,0.01,
uncorrected) (Table 2, Table S7 in File S2).
Comparative analysis of the core genome
Analysis of the core genome identified in total approximately
13,000 gene variants by edit distance analysis. Different Pfam
domains, and therefore different protein sequences, were observed
in 13 of these gene variants (Table S8 in File S2). Comparison of
core gene variants among LEE positive STEC (n= 54, Table S1 in
File S1) identified 281 gene variants that were overrepresented in
the HUS-associated (n = 23) compared to non-HUS strains
(n = 31) (p,0.01, FDR) (Table 2, Table S9 in File S2). None of
the gene variants were however found only among HUS-
associated strains.
PLS regression of the core gene variants in serogroup O26
strains in HUS-group 2 discriminated stx2 positive O26 (n= 8)
from stx1 positive O26 strains (n = 10) (data not shown). Eighty-
seven gene variants were more frequent in stx2 positive O26
strains compared to stx1 positive strains of the same serogroup (p,
0.01, data uncorrected) (Table 2, Table S10 in File S2), but none
of these gene variants were exclusive for the group of stx2 positive
strains. Eighty-four gene variants were more common in the O26
Figure 1. Core gene phylogeny of the 95 sequenced non-O157 STEC and 14 E. coli reference genomes. The tree was rooted in Figtree
(http://tree.bio.ed.ac.uk/software/figtree/) by midpoint rooting. For an unrooted version of the phylogenetic tree, see Figure S1. The E. coli
phylogroups are marked with the colours blue (A), green (B1), orange (B2), yellow (D), ochre (F) and indigo (E). Bootstrap values were scaled from 0–1,
and blue circles indicate a bootstrap value of $0.8. LEE positive STEC were marked with N, while all HUS and HUS-associated STEC included in the
study were indicated with red letters.
doi:10.1371/journal.pone.0111788.g001
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strains which were HUS or HUS-associated (n = 5) compared to
the O26 non-HUS strains (n = 13) (p,0.1, data uncorrected)
(Table 2, Table S11 in File S2), but also in this case none of the
variants were exclusive to either group.
Comparison of HUS and non-HUS STEC from specific
outbreaks
Comparative analysis on gene content was furthermore
performed on specific HUS and non-HUS STEC that were
epidemiologically linked and belonged to the same MLVA
(Multiple Loci VNTR Analysis) outbreak cluster (Table S1 in File
S1). In HUS-strain FHI4 (Table S12 in File S3) we identified 179
genes (Table S13 in File S3) which were absent in the non-HUS
strain FHI3 (Table S12 in File S3) from the same outbreak. The
majority of the genes were related to various mobile genetic
elements integrated in the bacterial chromosome, Nle effectors
(Table S13 in File S3) or plasmid pO26_1 (AP010954) (Table S13
in File S3). A closer search revealed additional plasmid genes on
other contigs in the FHI4 draft genome, indicating the presence of
a complete pO26_1 plasmid in this strain, while the corresponding
genes were not found in strain FHI3. In HUS-strain FHI48 we
identified 153 genes (Table S14 in File S3) that were absent in the
non-HUS strains FHI43 and FHI62 from the same outbreak
cluster. Again, most of the genes were related to mobile genetic
elements (Table S14 in File S3). In the two HUS strains FHI58
and FHI63 from another outbreak, we identified 54 genes
exclusive to these two strains (Table S15 in File S3), while another
506 genes were present only in the non-HUS strain St. Olav104.
The genes in the two HUS strains were related to various
functions, while in the non-HUS strain, the majority of the genes
were related to mobile genetic elements and several Nle effectors
(Table S15 in File S3).
Gene ontology enrichment analysis
Gene ontology (GO) analysis of genes significantly overrepre-
sented in the 23 HUS-associated STEC strains (Table S3 in File
S2) revealed that nine GO terms in biological processes were
enriched in these strains. The enriched terms specified metabolic
and catabolic processes related to degradation of L-idonate
(GO:0046183) (Table S16 in File S4).
Among the 357 genes more frequent in HUS-group 1 (Table S5
in File S2), we identified six enriched GO terms, in biological
processes (n = 4), molecular functions (n = 1) and cellular compo-
nents (n = 1) (Table S17 in File S4). Also in this case we identified
enrichment in GO terms related to degradation of L-idonate
(GO:0046183, GO:0003939, GO0019523). In biological processes
and cellular components, we furthermore identified enriched GO
terms related to protein secretion by the type II secretion system
(GO:0015628, GO:0015627) (Table S17 in File S4).
Twenty-six GO terms were enriched in HUS-group 2 (Table S6
in File S2); in biological processes (n = 11), molecular function
(n= 4) and cellular components (n = 11) (Table S18 in File S4). In
biological processes, enriched terms were for siderophore biosyn-
thetic process (GO:0019290) and ciliary or bacterial-type flagellar
motility (GO:0001539) (Table S18 in File S4). For molecular
function we identified enrichment in terms for motor activity
Table 2. Overview of the different subgroups of STEC that were compared in this study.
Gene
source Groups defined by
Groups of strains
that were compared
Number of genes
overrepresented in
group
False discovery
rate (FDR)
Number of genes or gene
variants unique to group
Accessory
genome
Clinical and
epidemiological
information
LEE+/stx2+ HUS1 n= 23 11 #0.01 0
Other LEE+ non-HUS n= 31 4 #0.01 0
LEE+/stx2+ HUS1 n= 23 69 $0.01 0
LEE+/stx2+ non-HUS n= 10 44 $0.01 0
Core gene
phylogeny
HUS-group 1 (LEE+) n = 18 357 #0.01 12
LEE+ other than HUS-group 1 n= 36 365 #0.01 0
HUS-group 2 (LEE+) n = 23 576 #0.01 4
LEE+ other than HUS-group 2 n= 31 218 #0.01 0
LEE+ O26 HUS1 n= 5 17 $0.01 0
O26 non-HUS n= 13 13 $0.01 0
Core
genome
Clinical and
epidemiological
information
LEE+/stx2+ HUS1 n= 23 281 #0.01 0
Other LEE+ non-HUS n= 31 0 #0.01 0
Core gene
phylogeny
O26 stx2+ n= 8 87 $0.01 0
O26 stx1+ n= 10 83 $0.01 1
O26 HUS1 n = 5 84 $0.01 0
O26 non-HUS n= 13 78 $0.01 0
In the upper half of the table, different groups were compared with respect to gene content in the accessory genome. In the lower half, the groups were compared with
respect to gene variants in the core genome.
1HUS: HUS-associated STEC.
2The gene was not exclusive to this group as it was also found in one LEE negative STEC.
doi:10.1371/journal.pone.0111788.t002
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(GO:0003774), isochorismate synthase activity (GO:0008909) and
oxo-acid-lyase activity (GO:0016833), while for cellular compo-
nents we found enrichment in terms for bacterial-type flagellum
basal body and rod (GO:0030694) (Table S18 in File S4). None of
the enriched GO terms were however unique for the HUS-
associated STEC strains.
Accession numbers
The nucleotide sequences are submitted to the European
Nucleotide Archive with accession numbers ERS480133–
ERS480228. Study accession number is PRJEB6447.
Discussion
In this study we have performed comparative genomic analyses
on what to our knowledge is the largest collection so far of
genome-sequenced non-O157 STEC strains, in order to investi-
gate if there were genetic differences suitable for distinguishing
between highly pathogenic STEC having caused HUS and low-
virulent STEC having caused only mild disease or asymptomatic
carriage. Whole genome sequencing and comparison revealed that
there was considerable heterogeneity in genetic content across the
95 non-O157 STEC strains included in the study. The approx-
imately 24,000 genes constituting the accessory genome contribute
to this heterogeneity, while 1,954 core genes were shared by all the
sequenced strains. Much of the accessory genome contained
various mobile genetic elements, which have also previously been
shown to contribute to heterogeneity and pathogenic evolution in
E. coli [24–26,30,36]. The results from principal component
analysis of the accessory genome where LEE positive strains were
separated from LEE negative strains, is in line with several
previous reports [14,20,28,37–42]. Although the accessory ge-
nome was not identical within LEE positive STEC strains, further
PCA analysis of LEE positive strains showed scattering of the
strains without any distinct subgroups. Furthermore, although
random forest analysis showed a slightly better classification than
PCA, it could not classify all strains correctly, indicating that
variable accessory gene content was heterogeneously distributed
within this group.
The various stx1 and stx2 subtypes were differentially distrib-
uted between LEE positive and LEE negative STEC strains, i.e.
stx2b and stx1c were more frequent among LEE negative strains
(p,0.05) while stx2a was more frequent among LEE positive
strains (p,0.05) (Table 1). All HUS associated STEC in this study
were LEE positive and contained stx2a, except for the STEC-LST
(strains that have lost Shiga toxin). Thus our results are in
accordance with previous studies where Stx2a has been shown to
possess higher potency than Stx1 and other Stx2 subtypes [43],
and that LEE positive and stx2a positive STEC strains are more
often associated with severe disease [12–15,43]. Furthermore, all
the HUS-associated STEC belonged to E. coli O serogroups
known to be associated with STEC disease (Table S1 in File S1)
[1]. However, although stx2a and LEE were typical for the HUS-
associated STEC, these characteristics are not unique for such
STEC, and thus not sufficient to clearly distinguish HUS-
associated from non-HUS STEC. We therefore aimed to compare
the accessory genomes of stx2a/LEE positive STEC in an attempt
to differentiate between HUS-associated and non-HUS strains.
This analysis revealed that certain genes were overrepresented
among HUS-associated STEC (Table 2, Tables S3, S4 in File S2),
suggesting that strains with this gene profile have a high
pathogenic potential. However, none of the genes were exclusive
for these strains, which further suggest that the gene content in
HUS-associated STEC at least in part is shared with non-HUS
STEC strains, or that different HUS strains have different gene
content.
Core genome phylogeny revealed that the 95 non-O157 STEC
strains were distributed over all the E. coli phylogroups except
phylogroup F, confirming that the strains included in this study
were heterogeneous. The majority of strains belonged to
phylogroup B1 (Figure 1). Most of the LEE positive and all the
HUS-associated strains in this study also clustered in this
phylogroup, similarly to what has been reported in previous
studies [15,28,31,33,44]. In addition, LEE negative STEC
associated with HUS often belong to this phylogroup [20,33],
including the O104:H4 strain (FHI102) related to the 2011
German outbreak, which did however not cluster with any of the
HUS and HUS-associated STEC strains in this study (Figure 1).
LEE negative and LEE positive STEC did not form separate
phylogenetic clusters, but were mixed in small clusters within
several phylogroups as previously reported [20]. This indicates
that the LEE pathogenicity island has been independently taken
up by different STEC lineages at different time points. Because
HUS-associated O103, O121 and O145 strains were distributed in
three related clusters in the phylogenetic analysis, these STEC
strains were classified as HUS-group 1, although they did not
belong to one defined cluster. The remaining HUS-associated
strains were located in one cluster which we termed HUS-group 2.
This clustering of HUS-associated strains based on variation in
core genes as observed in this study indicates that the phylogenetic
backgrounds of the bacteria at least to some extent determine the
pathogenic potential of the organism. In an attempt to search for
unique genes in these groups, we analysed the accessory genome
and identified several hundred genes that were significantly
overrepresented in both groups, suggesting that different sets of
genes may contribute to the pathogenic potential in different
phylogenetic STEC lineages. However, few of these genes were
found to be unique to any of the groups (Table 2, Tables S5, S6 in
File S2), which further suggest that the accessory genome is shared
both between and within the different clusters defined by the core
genome phylogeny.
The majority of strains in HUS-group 2 were of serotype O26,
of which HUS-associated strains clustered with non-HUS strains,
suggesting that accessory factors rather than core genes defines
pathogenic potential within this group. Regardless, it was not
possible to identify any genes in the accessory genome which could
reliably distinguish HUS-associated from non-HUS strains of the
same serogroup in HUS-group 2 (Table 2).
In the core genome of the 95 STEC strain included in this
study, we identified approximately 13,000 different gene variants
by edit distance analysis. However, despite the high number of
gene variants, differences in protein sequences were identified for
only 13 of these variants. Comparison of the core gene variants
revealed that although 281 gene variants were overrepresented in
HUS-associated STEC, several of these were also present in strains
not associated with HUS (Table 2, Table S9 in File S2). The
observation that none of the identified gene variants were unique
to HUS-associated STEC is supported by the fact that HUS-
associated strains clustered to more than one group in the core
gene phylogeny. Also for the O26 strains, although PLS regression
revealed that serogroup O26 strains in HUS group 2 containing
stx2 were separated from strains that contained stx1, no core gene
variants were found to be significantly over- or underrepresented
in either of these two groups (Table 2, Table S10 in File S2).
By comparing the genomes of the STEC strains which were
epidemiologically linked and belonged to the same MLVA
outbreak cluster (Table S1 in File S1), we identified a number of
genes that were different across HUS and non-HUS strains (Table
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S12 in File S3). The fact that different genes were present in strains
from the same outbreak might indicate that the infecting source
consisted of a mixture of similar but not identical STEC which
could have evolved from the same clone. Regardless, we could not
identify any genes that clearly distinguished between the HUS and
non-HUS associated strains within each of these outbreak clusters.
GO terms related to L-idonate degradation were found to be
enriched both among all 23 HUS-associated STEC strains
collectively and the strains in HUS-group 1. E. coli is able to
utilize L-idonate as a sole carbohydrate source through the
Entner-Doudoroff metabolic pathway, which has been shown to
be important for the ability of E. coli to colonize mammalian
intestines [45]. In addition, we identified enriched GO terms for
protein secretion by the type II secretion system in HUS-group 1.
The type II secretion system in Gram negative bacteria promotes
protein transport across the outer membrane, and the majority of
proteins exported by this system contribute to bacterial adaptation
and colonization by generating nutrients available for uptake [46].
Furthermore, certain exported lipoproteins have been shown to be
involved in biofilm formation in EPEC [47]. Genes responsible for
the enriched GO terms could therefore contribute to enhanced
bacterial colonization and adaptation, which might have an
impact on bacterial virulence in these specific strains. This
however needs to be confirmed in further investigations. Of the
26 GO terms that were enriched in HUS group 2, a few were
related to flagellar motility, which in general are recognized as
virulence factors in bacteria [48]. In addition, enriched GO terms
were related to siderophore biosynthesis. Siderophores, being iron
chelating compounds, are important for iron acquisition in
bacteria [49,50]. The specific siderophore identified among strains
in HUS-group 2 was encoded on a high-pathogenicity island (HPI)
found in a distinct clonal lineages of STEC, which includes
serogroup O26 [51,52]. These results indicate that both motility
and iron acquisition might be important factors for bacterial
virulence of STEC in HUS-group 2. However, the precise role of
these genes for STEC pathogenesis needs to be explored in further
studies.
In addition to bacterial factors, it is clear that infection dose and
host factors like the immune system, expression of the Shiga toxin
receptor and intestinal environment might also affect STEC
virulence, and thus severity of STEC disease [53]. In this study, all
patients with HUS were ,5 years old, which is known to be a risk
factor for severe STEC disease [54,55]. Unfortunately we could
not obtain further information on host factors, but it is possible
that such factors play an important part in explaining why highly
similar strains lead to such different clinical outcomes in different
patients.
In our study we included all non-O157 STEC strains from
HUS-patients in Norway. However, these represent only a limited
number of STEC strains from each phylogenetic lineage or
serotype. Furthermore, few epidemiologically linked HUS and
non-HUS STEC strains were included in the study. For future
studies, if more STEC strains associated with HUS were included
in the genomic comparisons this would give more strength both to
phylogenetic and to statistical analyses. In addition, even if highly
virulent STEC strains share overlapping genetic content with less
pathogenic strains, further investigations regarding factors regu-
lating transcription and translation as well as transcriptomics and
proteomics analyses could shed further light into STEC virulence
and pathogenicity.
Conclusion
In this study whole genome sequencing and comparisons of 95
non-O157 STEC strains revealed that there were considerable
genetic and phylogenetic heterogeneity between the strains.
Although all HUS-associated STEC strains belonged to the B1
phylogroup, all non-O157 STEC from HUS patients did not
cluster together, but were found in two separate clusters within this
phylogenetic group. A clear difference in gene profile was
observed between LEE positive and LEE negative STEC. A
number of accessory genes were found to be significantly
overrepresented among HUS-associated STEC, but none of them
were unique to this group of strains. Our results indicate that
STEC from different phylogenetic backgrounds independently
have acquired virulence genes that determine pathogenic poten-
tial, and that specific genes overrepresented among HUS strains
are not necessarily shared by all such strains, but that different sets
of genes may contribute to the pathogenic potential in different
phylogenetic STEC lineages.
Materials and Methods
Bacterial strains and clinical information
We selected 94 non-O157 STEC strains from the strain
collection at the Norwegian Institute of Public Health (Oslo,
Norway) isolated in 2000–2012 for sequencing in this study (Table
S1 in File S1). In addition, three STEC strains (St. Olav104, St.
Olav143 and St. Olav172, Table S1 in File S1) were selected from
the strain collection at St. Olavs Hospital (Trondheim, Norway).
The strains included in the study were primarily selected to
represent different MLVA genotypes [56,57], a diversity of non-
O157 STEC serotypes and patients with different severity of
disease (Table S1 in File S1). All available non-O157 STEC strains
isolated from patients with HUS (n= 20) in Norway were
included, except one strain (FHI10) which after whole genome
sequencing was shown to be contaminated (Table S1 in File S1).
Thus, a total of 96 strains were included in the study (Table S1 in
File S1).
Some of the STEC strains from patients with HUS were from
outbreaks and therefore had identical MLVA-genotypes or
belonged to the same MLVA-genotype clusters (Table S1 in File
S1). Four of the STEC strains included were furthermore classified
as HUS-associated because they had identical MLVA-genotype as
or belonged to the same MLVA-genotype cluster as a HUS case
(Table S1 in File S1). Five of the STEC strains were from non-
human sources and were isolated during various outbreak
investigations related to STEC disease (Table S1 in File S1).
One of these was designated as HUS-associated (FHI16, Table S1
in File S1). Of the total 96 STEC strains included in the study, 95
strains were included for genomic comparison throughout the
whole study whereas one strain (St. Olav104) was included for
parts of the study only. In addition, 14 E. coli were included as
reference strains for classification of the STEC strains into the E.
coli phylogroups A, B1, B2, D, E, and F (Table S1 in File S1).
Primary characterization of STEC at the Norwegian Institute of
Public Health and St. Olavs Hospital had been based on PCR for
the stx1, stx2 and eae genes [58–60]. Ninety-one strains then had
contained the stx1 and/or stx2 genes, while six strains of serotype
O103:H25 did not have stx genes at inclusion time (Table S1 in
File S1). The six stx gene negative O103:H25 strains were included
in the study because they were isolated from patients with HUS in
an outbreak (five strains), or was isolated from fermented sausage
linked to this specific outbreak (one strain) [61] (Table S1 in File
S1). In this outbreak, stx2a was detected in only two of the isolated
Genomic Comparison of Non-O157 Shiga Toxin-Producing Escherichia coli
PLOS ONE | www.plosone.org 7 October 2014 | Volume 9 | Issue 10 | e111788
strains. As stx negative derivates of STEC causing HUS
occasionally are shed by HUS patients, the six strains without
stx genes were regarded as STEC that had lost their stx genes,
often termed EHEC/STEC-LST [62]. Fifty-five of the STEC
strains were positive for the LEE pathogenicity island, as detected
by the presence of the eae gene.
Serotyping was performed at the National Reference Labora-
tory for Enteropathogenic Bacteria at the Norwegian Institute of
Public Health, using monospesific O:K and H antisera by a
combination of in-house antisera before 2002, and by antisera
from Sifin (Germany) and SSI (Denmark) after 2002, covering
altogether 44 O-serogroups including O26, O103, O111, O121,
O145, O157; and 8 H-antigens. Twenty-four of the strains
included in the study did not belong to any of the serogroups tested
for (Table S1 in File S1).
Ethics Statement
This experimental study was approved by the Regional
Committee for Medical and Health Research Ethics, REC
South-East (REC number 2011/2314). Clinical data (including
age and gender) required for classification of patients into the
groups HUS, bloody diarrhoea, diarrhoea and no disease were
obtained from Norwegian Surveillance System for Communicable
Diseases (MSIS) at the Norwegian Institute of Public Health
(Table S1 in File S1). Dispensation from professional secrecy
requirements was given by the REC. As data were analysed
anonymously informed consent was not obtained.
DNA isolation
Strains were grown overnight on MacConkey agar. Genomic
DNA was isolated for each strain using the Qiagen MagAttract
DNA Mini M48 Kit and the Qiagen BioRobot M48 (Qiagen,
Hilden Germany) as described by the manufacturer.
Whole genome sequencing
Ninety-six of the STEC strains were sequenced with the
Illumina Technology, while one strain (St. Olav104) was
sequenced with Pacific Biosciences (PacBio) Technology (Table
S1 in File S1).
For the strains to be sequenced by Illumina technology a
standard read library of bacterial genomic DNA was prepared,
with an average fragment length of 370 base pairs (bp). The DNA
was sequenced by LGC Genomics (Berlin, Germany) on the
Illumina HiSeq2000 platform (Illumina, San Diego, CA, USA)
with 100 bp paired-end reads. Assembly and scaffolding of
processed and error corrected paired-end reads was done using
Velvet 1.2.04 [63]. Information on the resulting draft genome for
each strain is given in Table S1 in File S1.
Forty-eight of the 96 strains were selected for additional mate
pair sequencing (Table S1 in File S1). For this purpose a 2 kb
Illumina Mate Pair library was prepared and the DNA was
sequenced by LGC Genomics (Berlin, Germany) on the Illumina
HiSeq2000 platform with 100 bp paired-end reads. Assembly and
scaffolding of processed and error corrected paired-end reads was
performed using Allpaths-LG release 45553 [64]. Gap closure of
assembly scaffolds was done using SOAP GapCloser version 1.12
[65], while refinement of gap-closed scaffolds was done using
SEQuel version 1.0.2 [66]. Information on the resulting draft
genome for each strain is given in Table S1 in File S1.
Genome sequencing on the PacBio platform was performed at
the Norwegian Sequencing Centre (Oslo, Norway). A library was
prepared using the Pacific Biosciences 10 kb library preparation
protocol, and size selection of the final library was performed using
Ampure beads. The library was sequenced on a Pacific Biosciences
RS II instrument (Pacific Bioscience, Menlo Park, CA, USA) using
P4-C2 chemistry and three SMRT cells. Processed reads were
assembled using HGAP v2 [67]. Information on the resulting draft
genome is given in Table S1 in File S1.
Gene annotation
Identification of open reading frames was performed using the
Prodigal Microbial Gene Prediction Software [68], and functional
gene annotation was done using myRAST [69].
Comparative analyses
The CMG-biotools (Comparative Microbial Genomics) pack-
age was used for genome comparison [70]. Blastmatrix in CMG-
biotools was used to identify proteins shared between genomes,
while pancoreplot was used to identify the pan- and core-genome
of the sequenced strains. In this context, genes were considered to
be homologs having at least 90% sequence identity over at least
60% alignment length. The accessory genome was defined by
subtracting all core genes from the pan genome. Genome analysis
and comparison was performed across all sequenced STECs
(Table S1 in File S1) except strain St. Olav104 which was only
used for comparison with two HUS-strains (FHI58 and FHI63).
Core genome phylogeny
E. coli phylotypes were determined in silico based on a core
gene tree. This was created as described by Kaas et al. [33] using
1,861 core genes present in all the 95 STEC genomes and
additional 14 E. coli reference genomes (109 genomes in total)
representing the E. coli phylotypes A, B1, B2, D, E and F (Table
S1 in File S1) [28,33,71–73].
Core gene analysis
Core gene nucleotide sequences (n = 1,861) from the 95 STEC
and 14 reference E. coli (Table S1 in File S1) were aligned
separately and a consensus sequence was estimated for each of the
1,861 genes using EMBOSS 6.3.1 [74]. A python implementation
of the edit distance method [75] was used to quantify the
difference between the consensus sequence and the corresponding
sequence of each core gene for all 109 strains included in the
analysis. This resulted in various edit distances, representing
different gene variants for each of the core genes. Edit distance
values for all strains were normalized and transformed into a
binary matrix for core gene comparisons.
To examine if any gene variant from the same core gene family
showed different Pfam domains, we used pfam_scan.pl with the
HMMER3 library of Pfam domains.
Principal component analysis and Partial least squares
regression
For Principal component analysis (PCA) and Partial least
squares (PLS) regression the Laydi software (http://www.laydi.
org) (unpublished) was used. For PLS regression, dependent
variables (for the Y-matrix) were the clinical diagnosis HUS or
classification as HUS-associated, and the presence of stx1 and/or
stx2. HUS and HUS-associated STEC-LST were classified as stx2
positive for these analyses.
Random forest analysis
Random forest analysis was performed using the randomForest
package in R software package version 3.03 (R: A Language and
Environment for Statistical Computing, http://www.R-project.
org).
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Functional annotation and Gene Ontology enrichment
analysis
Blast2GO was used for functional annotation based on gene
ontology (GO) and for GO enrichment analysis [76,77].
Subtyping of Stx1 and Stx2
There are three known subtypes of Stx1 and seven known
subtypes of Stx2, designated Stx1a, Stx1c and Stx1d, and Stx2a
through Stx2g, respectively. Reference protein sequences were
downloaded for each Stx subtype and Stx type variant from
GenBank [13]. Amino acid sequences of the A and B subunits
were concatenated and aligned separately for Stx1 and Stx2 using
Clustal O in Jalview [78,79]. For cluster analysis and tree
calculations the Neighbour Joining algorithm in Jalview using %
identity was used. Clustering of the Stx protein sequences of the
sequenced strains with reference sequences was used to classify the
former into Stx1 and Stx2 subtypes.
Statistical analysis
Fisher’s exact test was used to analyse if specific stx subtypes
were differently distributed in LEE positive and LEE negative
STEC, with a p-value #0.05 regarded as statistically significant.
Fisher’s exact test was also used to test if specific genes in the
accessory genome were overrepresented, and for overrepresenta-
tion of gene variants in the core genome, in subgroups of the 95
STEC strains. Classification of the strains into subgroups was
based on clinical and outbreak investigation information, phylo-
genetic analysis, and PCA and PLS regression (Table 2). For
corrections of false discovery rate (FDR) in multiple testing the
Benjamini-Hochberg method was used, with FDR#0.01 regarded
as statically significant. Whenever no significant association was
identified after FDR correction, results for uncorrected analysis
are given. The statistical analyses were performed using the R
software package version 3.03 (R: A Language and Environment
for Statistical Computing, http://www.R-project.org). In addition,
in Blast2GO, Fisher’s exact test was used for GO enrichment
analysis.
Supporting Information
Figure S1. Unrooted core gene phylogeny. Unrooted core gene
tree of the 95 sequenced non-O157 STEC and 14 E. coli reference
genomes. The E. coli phylogroups are marked with the colours
blue (A), green (B1), orange (B2), yellow (D), ochre (F) and indigo
(E). LEE positive STEC were marked with a #-sign, while all
HUS and HUS-associated STEC included in the study were
coloured with red letters. HUS-group 1 consisted of 18 STEC
strains in three related clusters, mainly strains of serotypes
O103:H25, O145:H[unknown], and O121:H-. HUS-group 2
consisted of 23 STEC strains in one cluster, mainly strains of
serogroups O26, O86 and O111.
(TIFF)
Figure S2. Heat map of the random forest classification of
accessory genes in HUS- and non-HUS-strains. The one hundred
genes that contributed most to the random forest classification
were included. In the upper solid coloured line, HUS-strains are
defined by blue colour and non-HUS-strains with red colour.
Genes present are indicated by beige colour, while genes absent
are indicated by red colour. In this classification, two HUS-strains
were incorrectly classified as non-HUS-strains, while three non-
HUS-strains were incorrectly classified as HUS-strains.
(TIFF)
File S1. Contains Table S1. Information on 95 Norwegian non-
O157 STEC genomes sequenced and analysed in this study.
(XLSX)
File S2. Contains Tables S2–S11. Statistical analysis of acces-
sory and core genes in the 95 sequenced Norwegian non-O157
STEC strains.
(XLSX)
File S3. Contains Tables S12–S15. Analysis of genes present in
HUS- and non-HUS-strains from the same outbreaks.
(XLSX)
File S4. Contains Tables S16–S18. Gene ontology analysis of
genes overrepresented in HUS-associated strains.
(XLSX)
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